Netflix gave a forecast for the second quarter that fell short of analysts expectations, sending the shares down in extended trading. The streaming pioneer also announced that chairman and co-founder Reed Hastings is stepping down from the board after 29 years to pursue philanthropy and personal interests. (Source: Bloomberg)
Netflix gave a forecast for the second quarter that fell short of analysts expectations, sending the shares down in extended trading. The streaming pioneer also announced that chairman and co-founder Reed Hastings is stepping down from the board after 29 years to pursue philanthropy and personal interests. (Source: Bloomberg)
Key PointsAst Spacemobile currently generates significantly less revenue than Iridium Communications, though the gap between the two companies has noticeably narrowed.
Key PointsAst Spacemobile currently generates significantly less revenue than Iridium Communications, though the gap between the two companies has noticeably narrowed.
On Thursday, OpenAI announced it had developed a large language model specifically trained on common biology workflows. Called GPT-Rosalind after Rosalind Franklin , the model appears to differ from most science-focused models from major tech companies, which have generally taken a more generic approach that works for various fields. In a press briefing, Yunyun Wang, OpenAI's Life Sciences Product...
On Thursday, OpenAI announced it had developed a large language model specifically trained on common biology workflows. Called GPT-Rosalind after Rosalind Franklin , the model appears to differ from most science-focused models from major tech companies, which have generally taken a more generic approach that works for various fields. In a press briefing, Yunyun Wang, OpenAI's Life Sciences Product Lead, said the system was designed to tackle two major roadblocks faced by current biology researchers. One is the massive datasets created by decades of genome sequencing and protein biochemistry, which can be too much for any one researcher to take in. The second is that biology has many highly specialized subfields, each with its own techniques and jargon. So, for example, a geneticist who finds themselves working on a gene that's active in brain cells might struggle to understand the immense neurobiological literature. Wang said the company had taken an LLM and trained it on 50 of the most common biological workflows, as well as on how to access the major public databases of biological information. Further training has resulted in a system that can suggest likely biological pathways and prioritize potential drug targets. "We're connecting genotype to phenotype through known pathways and regulatory mechanisms, infer likely structural or functional properties of proteins, and really leveraging this mechanistic understanding," Wang said. Read full article Comments
Hims & Hers Health (NYSE:HIMS), a consumer-focused telehealth platform offering prescription and non-prescription health products, closed Thursday at $26.98, up 11.07%. The stock moved higher as investors reacted to the FDA’s decision to review compounded peptide therapies. T
Hims & Hers Health (NYSE:HIMS), a consumer-focused telehealth platform offering prescription and non-prescription health products, closed Thursday at $26.98, up 11.07%. The stock moved higher as investors reacted to the FDA’s decision to review compounded peptide therapies. T
SpaceX has moved up a scheduled vesting date for shares awarded to employees to as soon as next week, according to people familiar with the matter, ahead of an IPO targeted to value the company at more than $2 trillion. The company told employees the vesting date — when shares granted as stock options become eligible for sale — would take place in April rather than the expected date in May, the pe...
SpaceX has moved up a scheduled vesting date for shares awarded to employees to as soon as next week, according to people familiar with the matter, ahead of an IPO targeted to value the company at more than $2 trillion. The company told employees the vesting date — when shares granted as stock options become eligible for sale — would take place in April rather than the expected date in May, the people said. The accelerated vesting is expected to help assuage staffers’ concerns over how much stock they have available to sell when the company goes public. The move is another sign that billionaire Elon Musk ’s rocket, satellite and artificial intelligence company is nearing a public filing for its initial public offering, which would be the biggest of all time if the company achieves its fundraise goal of as much as $75 billion. SpaceX is expected to file publicly later in May for the IPO and to price the week of June 15, people familiar with the matter have said. Read More: SpaceX Plans Site Visits for Large Investors as Mega-IPO Nears The vesting schedule change would also happen as Musk works to rebuild xAI, which was acquired by SpaceX earlier this year. The billionaire is cutting staff and hiring new talent from other AI firms, after core employees, including some of the AI company’s founding members, left the firm. Companies going public typically indicate in their initial public offering filings with the US Securities and Exchange Commission how many shares will be eligible for sale on the first trading day, as well as stock options that have been granted to employees. Deliberations are ongoing and details of the IPO including timing could change, the people said, asking not to be identified as the information isn’t public. A representative for SpaceX didn’t immediately respond to a request for comment. Strong demand for SpaceX’s stock — particularly from fans of Musk’s companies — would create a windfall for existing shareholders. SpaceX would potentially be el...
(Bloomberg) -- SpaceX has moved up a scheduled vesting date for shares awarded to employees to as soon as next week, according to people familiar with the matter, ahead of an IPO targeted to value the company at more than $2 trillion.The company told employees the vesting date — when shares granted as stock options become eligible for sale — would take place in April rather than the expected date ...
(Bloomberg) -- SpaceX has moved up a scheduled vesting date for shares awarded to employees to as soon as next week, according to people familiar with the matter, ahead of an IPO targeted to value the company at more than $2 trillion.The company told employees the vesting date — when shares granted as stock options become eligible for sale — would take place in April rather than the expected date in May, the people said. The accelerated vesting is expected to help assuage staffers’ concerns over
EDO President & CEO Kevin Krim discusses Netflix’s big push into broadcasting live events, especially live sports, referring to them as ‘the engine that powers the whole ecosystem.’ He talks with Romaine Bostick and Katie Greifeld on “The Close.” (Source: Bloomberg)
EDO President & CEO Kevin Krim discusses Netflix’s big push into broadcasting live events, especially live sports, referring to them as ‘the engine that powers the whole ecosystem.’ He talks with Romaine Bostick and Katie Greifeld on “The Close.” (Source: Bloomberg)
Los Jornaleros Del Norte play protest songs whose lyrics reflect the hopes and struggles of undocumented workers as they evade immigration agents patrolling the streets. (Image credit: Adrian Florido)
Los Jornaleros Del Norte play protest songs whose lyrics reflect the hopes and struggles of undocumented workers as they evade immigration agents patrolling the streets. (Image credit: Adrian Florido)
Ross Gerber, Gerber Kawasaki Wealth and Investment Management co-founder, president and CEO, says Netflix is in a phenomenal position and just "keeps printing money." Netflix gave a forecast for the second quarter that fell short of analysts expectations. Gerber speaks on "Bloomberg The Close." (Source: Bloomberg)
Ross Gerber, Gerber Kawasaki Wealth and Investment Management co-founder, president and CEO, says Netflix is in a phenomenal position and just "keeps printing money." Netflix gave a forecast for the second quarter that fell short of analysts expectations. Gerber speaks on "Bloomberg The Close." (Source: Bloomberg)
What a time it is to be a Crystal Palace supporter. Twelve months ago, the south London club was still waiting to win their first major trophy and even the most optimistic fan could never have imagined that they would be contesting the semi-final of a European competition. But despite a few anxious moments when a battling Fiorentina side cut the deficit from last week’s 3-0 defeat in first leg at ...
What a time it is to be a Crystal Palace supporter. Twelve months ago, the south London club was still waiting to win their first major trophy and even the most optimistic fan could never have imagined that they would be contesting the semi-final of a European competition. But despite a few anxious moments when a battling Fiorentina side cut the deficit from last week’s 3-0 defeat in first leg at Selhurst Park to just two goals with half an hour still to play, Oliver Glasner’s side showed their growing maturity at this level to progress to a last four showdown with Shakhtar Donetsk. Continue reading...
May WTI crude oil (CLK26 ) on Thursday closed up +3.40 (+3.72%), and May RBOB gasoline (RBK26 ) closed up +0.0945 (+3.08%). Crude oil and gasoline prices rallied sharply on Thursday as the US naval blockade of the Strait of Hormuz entered its fourth day, curbing oil supplies from the...
May WTI crude oil (CLK26 ) on Thursday closed up +3.40 (+3.72%), and May RBOB gasoline (RBK26 ) closed up +0.0945 (+3.08%). Crude oil and gasoline prices rallied sharply on Thursday as the US naval blockade of the Strait of Hormuz entered its fourth day, curbing oil supplies from the...
Defense and space stocks are having a moment. Whether due to the upcoming initial public offering ( IPO ) of SpaceX or the growing need for defense supplies amid conflicts around the world, investors are buying defense stocks for their portfolios at a rapid pace. This is all fine and well, but the sun doesn't always shine on the defense/war contractors, especially in programs that are experimental...
Defense and space stocks are having a moment. Whether due to the upcoming initial public offering ( IPO ) of SpaceX or the growing need for defense supplies amid conflicts around the world, investors are buying defense stocks for their portfolios at a rapid pace. This is all fine and well, but the sun doesn't always shine on the defense/war contractors, especially in programs that are experimental and bound for revisions, such as the Golden Dome missile defense system. If you have money to invest and want a prime contractor in the defense industry with the backlog to get through any Trump-era volatility, then Lockheed Martin (NYSE: LMT) may be just for you. If you have $7,500 available to invest, here's why you might want to put it toward buying and holding this stock for the long term. Continue reading